A Comparison of Provider Versus Health Plan Delivered Care Management in Michigan
密歇根州提供者与健康计划提供的护理管理的比较
基本信息
- 批准号:8060298
- 负责人:
- 金额:$ 185.9万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-09-30 至 2013-09-29
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (provided by applicant): Over 1 billion dollars is spent annually for contracted companies to deliver disease management programs to adults with chronic conditions, yet evidence of the effectiveness and cost savings of these programs is lacking. Published research suggests that the more disease management is integrated into a patient's primary health care setting, the more effective it is in improving patient outcomes and saving health care dollars. A head-to- head comparison of these approaches - disease management/health insurance company (i.e. vendor) based versus primary care practice (i.e. provider) based disease management - has not been studied. We have a special opportunity to study a demonstration project that seeks to do just that. Blue Cross Blue Shield of Michigan (BCBSM), in partnership with 45 practices from five selected physician organizations (POs), will begin a demonstration project to test provider-delivered chronic disease care management (PDCM). At the same time, BCBSM will continue to deliver their health plan-based (i.e. vendor based) program (HPDCM) for their members in practices not in the demonstration project. We take advantage of this natural experiment in community primary care settings to conduct a comparative effectiveness study of these two care management approaches for adult patients with one and more of five chronic conditions: asthma, chronic obstructive pulmonary disease, congestive heart failure, coronary artery disease, or diabetes. Using qualitative, quantitative and mixed methods, we will observe, measure and describe the implementation of PDCM in the intervention practices. Using the lens of the Normalization Process Model, we will examine the implementation processes, environments, and the degree of care management integration to identify best practices for PDCM. Finally, we will compare patient outcomes to determine the relative effectiveness of each model of care delivery. The study aims are to: 1) extensively describe the implementation of PDCM in the practices of selected POs (intervention) including the barriers, facilitators, models and features, methods used, and costs to accomplish implementation; 2) compare the following patient-specific outcomes between patients offered PDCM versus HPDCM: a) engagement rates in care management, b) relevant clinical indicators, and c) health care utilization; and 3) describe the practice environments and contexts in which BCBSM chronic disease patients receive their care and to identify care management implementation and practice features associated with improved patient engagement and patient-specific outcomes. Research is needed to determine which choice is the best to make with our finite health care dollars: care management delivered by practices and their care teams (PDCM) or care management delivered by health insurers or companies disconnected from practice (vendor based or HPDCM). This study will provide a direct comparison of these two approaches and utilize innovative methods to discover new insights regarding best practices for PDCM within context. Without such studies, comparative effectiveness research will likely have little impact on translating research into practice.
PUBLIC HEALTH RELEVANCE: Nearly one out of every two American adults has at least one chronic illness. Research has shown that care management services can improve chronic disease patient outcomes; however, it is unclear which health care entity is best positioned to provide the most cost-effective patient benefits. This study will compare provider- delivered care management (PDCM) to health plan-delivered care management (HPDCM); seeking to determine the comparative effectiveness of these two approaches on patient participation in care management, clinically relevant health indicators, and healthcare utilization.
描述(由申请人提供):签约公司每年花费超过10亿美元向患有慢性病的成年人提供疾病管理计划,但缺乏这些计划的有效性和成本节约的证据。已发表的研究表明,将疾病管理纳入患者的初级卫生保健环境越多,在改善患者预后和节省卫生保健费用方面就越有效。这些方法的头对头比较-基于疾病管理/健康保险公司(即供应商)与基于初级保健实践(即提供者)的疾病管理-尚未进行研究。我们有一个特殊的机会来研究一个旨在做到这一点的示范项目。密歇根州蓝十字蓝盾(BCBSM)与来自五个选定的医生组织(PO)的45个实践合作,将开始一个示范项目,以测试提供者提供的慢性病护理管理(PDCM)。与此同时,BCBSM将继续在实践中为其成员提供基于健康计划(即基于供应商)的计划(HPDCM),而不是在示范项目中。我们利用这个自然的实验,在社区初级保健设置进行比较有效性研究这两种护理管理方法的成人患者与一个或多个五种慢性疾病:哮喘,慢性阻塞性肺疾病,充血性心力衰竭,冠状动脉疾病,或糖尿病。采用定性、定量和混合方法,观察、测量和描述PDCM在干预实践中的实施情况。使用规范化过程模型的透镜,我们将检查实施过程,环境和护理管理整合的程度,以确定PDCM的最佳实践。最后,我们将比较患者的结果,以确定每种护理模式的相对有效性。研究的目的是:1)广泛描述PDCM在选定参与组织的实践中的实施情况(干预)包括障碍、促进者、模型和特征、使用的方法以及完成实施的成本; 2)比较提供PDCM与HPDCM的患者之间的以下患者特异性结果:a)护理管理中的参与率,B)相关临床指标,以及c)卫生保健利用;以及3)描述BCBSM慢性病患者接受护理的实践环境和背景,并确定与改善患者参与度和患者特定结局相关的护理管理实施和实践特征。需要研究来确定哪种选择是最好的,我们有限的医疗保健美元:由实践及其护理团队(PDCM)或医疗保险公司或与实践脱节的公司(基于供应商或HPDCM)提供的护理管理。本研究将提供这两种方法的直接比较,并利用创新的方法来发现新的见解PDCM的最佳实践背景下。如果没有这些研究,比较有效性研究可能对将研究转化为实践的影响不大。
公共卫生相关性:几乎每两个美国成年人中就有一个至少患有一种慢性疾病。研究表明,护理管理服务可以改善慢性病患者的预后;然而,目前还不清楚哪个医疗保健实体最适合提供最具成本效益的患者福利。本研究将比较提供者提供的护理管理(PDCM)和健康计划提供的护理管理(HPDCM);试图确定这两种方法在患者参与护理管理、临床相关健康指标和医疗保健利用方面的比较有效性。
项目成果
期刊论文数量(3)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
A Comparison of Health Plan- and Provider-Delivered Chronic Care Management Models on Patient Clinical Outcomes.
健康计划和提供者提供的慢性病护理管理模式对患者临床结果的比较。
- DOI:10.1007/s11606-016-3617-2
- 发表时间:2016
- 期刊:
- 影响因子:5.7
- 作者:Luo,Zhehui;Chen,Qiaoling;Annis,AnnM;Piatt,Gretchen;Green,LeeA;Tao,Min;Holtrop,JodiSummers
- 通讯作者:Holtrop,JodiSummers
Effect of care management program structure on implementation: a normalization process theory analysis.
- DOI:10.1186/s12913-016-1613-1
- 发表时间:2016-08-15
- 期刊:
- 影响因子:2.8
- 作者:Holtrop JS;Potworowski G;Fitzpatrick L;Kowalk A;Green LA
- 通讯作者:Green LA
Comparison of provider and plan-based targeting strategies for disease management.
比较提供者和基于计划的疾病管理目标策略。
- DOI:
- 发表时间:2015
- 期刊:
- 影响因子:0
- 作者:Annis,AnnM;Holtrop,JodiSummers;Tao,Min;Chang,Hsiu-Ching;Luo,Zhehui
- 通讯作者:Luo,Zhehui
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JODI Summers HOLTROP其他文献
JODI Summers HOLTROP的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JODI Summers HOLTROP', 18)}}的其他基金
PATHWEIGH: pragmatic weight management in primary care
PATHWEIGH:初级保健中的实用体重管理
- 批准号:
10681481 - 财政年份:2020
- 资助金额:
$ 185.9万 - 项目类别:
PATHWEIGH: pragmatic weight management in primary care
PATHWEIGH:初级保健中的实用体重管理
- 批准号:
10462658 - 财政年份:2020
- 资助金额:
$ 185.9万 - 项目类别:
PATHWEIGH: pragmatic weight management in primary care
PATHWEIGH:初级保健中的实用体重管理
- 批准号:
10264894 - 财政年份:2020
- 资助金额:
$ 185.9万 - 项目类别:
Why is use of the Medicare Intensive Behavioral Therapy for Obesity Benefit so low? Finding what works to promote wider dissemination.
为什么 Medicare 肥胖强化行为疗法福利的使用率如此之低?
- 批准号:
9216914 - 财政年份:2016
- 资助金额:
$ 185.9万 - 项目类别:
Implementing Sustainable Diabetes Prevention and Self-Management in Primary Care
在初级保健中实施可持续的糖尿病预防和自我管理
- 批准号:
8301005 - 财政年份:2010
- 资助金额:
$ 185.9万 - 项目类别:
Implementing Sustainable Diabetes Prevention and Self-Management in Primary Care
在初级保健中实施可持续的糖尿病预防和自我管理
- 批准号:
8107491 - 财政年份:2010
- 资助金额:
$ 185.9万 - 项目类别:
Implementing Sustainable Diabetes Prevention and Self-Management in Primary Care
在初级保健中实施可持续的糖尿病预防和自我管理
- 批准号:
8753789 - 财政年份:2010
- 资助金额:
$ 185.9万 - 项目类别:
Implementing Sustainable Diabetes Prevention and Self-Management in Primary Care
在初级保健中实施可持续的糖尿病预防和自我管理
- 批准号:
7885132 - 财政年份:2010
- 资助金额:
$ 185.9万 - 项目类别:
相似海外基金
Non-market strategy in service provider internationalization
服务提供商国际化的非市场战略
- 批准号:
24K16415 - 财政年份:2024
- 资助金额:
$ 185.9万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Healthcare provider perspectives on the role of healthbots in delivering care to patients taking varenicline for smoking cessation
医疗保健提供者对健康机器人在为服用伐尼克兰戒烟的患者提供护理方面的作用的看法
- 批准号:
492844 - 财政年份:2023
- 资助金额:
$ 185.9万 - 项目类别:
The Impact of Federal COVID-19 Provider Relief Funds on Patients, Hospitals, and Disparities
联邦 COVID-19 提供者救济基金对患者、医院和差异的影响
- 批准号:
10673511 - 财政年份:2023
- 资助金额:
$ 185.9万 - 项目类别:
Investigating facilitator-driven, multi-level implementation strategies in Federally Qualified Health Centers to improve provider recommendation and HPV vaccination rates among Latino/a adolescents
调查联邦合格健康中心中促进者驱动的多层次实施策略,以提高拉丁裔/非裔青少年的医疗服务提供者推荐和 HPV 疫苗接种率
- 批准号:
10737168 - 财政年份:2023
- 资助金额:
$ 185.9万 - 项目类别:
CO-LEADER: Intervention to Improve Patient-Provider Communication and Medication Adherence among Patients with Systemic Lupus Erythematosus
共同领导者:改善系统性红斑狼疮患者的医患沟通和药物依从性的干预措施
- 批准号:
10772887 - 财政年份:2023
- 资助金额:
$ 185.9万 - 项目类别:
Examining provider bias in an underserved dental patient population: Improving health equity through a Dental School Practice-based Research Network (dsPBRN)
检查服务不足的牙科患者群体中的提供者偏见:通过牙科学校实践研究网络 (dsPBRN) 改善健康公平
- 批准号:
10754446 - 财政年份:2023
- 资助金额:
$ 185.9万 - 项目类别:
Understanding Rural Patient, and Provider Preferences for Mobile Lung Cancer Screening Clinics
了解农村患者和提供者对流动肺癌筛查诊所的偏好
- 批准号:
10555009 - 财政年份:2023
- 资助金额:
$ 185.9万 - 项目类别:
Using patient-provider communication tools to improve hospital care and outcomes for patients with hearing loss
使用患者与提供者的沟通工具改善听力损失患者的医院护理和治疗结果
- 批准号:
488068 - 财政年份:2023
- 资助金额:
$ 185.9万 - 项目类别:
Operating Grants
GPgenie: A provider agnostic platform combining healthcare APIs with robotic process automations to complete most primary care administration tasks
GPgenie:一个与提供商无关的平台,将医疗保健 API 与机器人流程自动化相结合,以完成大多数初级保健管理任务
- 批准号:
10045413 - 财政年份:2023
- 资助金额:
$ 185.9万 - 项目类别:
Collaborative R&D
Understanding the experience, preferences and effects of provider payment mechanisms in Tanzania
了解坦桑尼亚提供商支付机制的经验、偏好和影响
- 批准号:
MR/V030736/1 - 财政年份:2023
- 资助金额:
$ 185.9万 - 项目类别:
Research Grant














{{item.name}}会员




